.Attribute Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint calls for addition of clients along with MASLD and measurement of liver end results in cardio-- kidney-- metabolic trials, when records suggest mechanistically plausible perks and also medical protection-- and also lays out factors for trial layout and governing commendation.